Spots Global Cancer Trial Database for locally advanced pancreatic ductal adenocarcinoma

Every month we try and update this database with for locally advanced pancreatic ductal adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma	NCT05688215	Borderline Rese... Locally Advance...	Biospecimen Col... Computed Tomogr... Core Biopsy Fluorouracil Irinotecan Leucovorin Leucovorin Calc... Oxaliplatin Quemliclustat Zimberelimab	18 Years -	Jonsson Comprehensive Cancer Center
PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)	NCT06345599	Pancreatic Duct...	Radiotherapy Immunotherapy:G... Chemotherapy:Al...	18 Years - 75 Years	Second Affiliated Hospital of Soochow University
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma	NCT06206876	Advanced Pancre... Locally Advance... Metastatic Panc... Refractory Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Biopsy Biospecimen Col... Computed Tomogr... DDX5 Degrader F... Magnetic Resona...	18 Years -	Roswell Park Cancer Institute
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma	NCT06398587	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Onvansertib Gemcitabine Nab-paclitaxel Electrocardiogr... Magnetic Resona... Positron Emissi... Biospecimen Col... Biospecimen Col... Computed Tomogr...	18 Years -	OHSU Knight Cancer Institute
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer	NCT04821284	Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Gemcitabine Hyd... Nab-paclitaxel Fluorouracil Irinotecan Hydr... Leucovorin Calc... Oxaliplatin Perflubutane Mi... Contrast-Enhanc... Quality-of-Life... Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study	NCT04481204	Borderline Rese... Locally Advance... Resectable Panc...	Cisplatin Fluorouracil Gemcitabine Irinotecan Leucovorin Nab-paclitaxel Oxaliplatin Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)	NCT04106856	Borderline Rese... Locally Advance... Locally Advance... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr...	Hypofractionate... Losartan Losartan Potass... Quality-of-Life... Questionnaire A...	18 Years -	University of Utah
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer	NCT04821284	Locally Advance... Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Gemcitabine Hyd... Nab-paclitaxel Fluorouracil Irinotecan Hydr... Leucovorin Calc... Oxaliplatin Perflubutane Mi... Contrast-Enhanc... Quality-of-Life... Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study	NCT04481204	Borderline Rese... Locally Advance... Resectable Panc...	Cisplatin Fluorouracil Gemcitabine Irinotecan Leucovorin Nab-paclitaxel Oxaliplatin Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Targeted Pathway Inhibition in Patients With Pancreatic Cancer	NCT04005690	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Cobimetinib Olaparib Onvansertib Azenosertib	18 Years -	OHSU Knight Cancer Institute
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer	NCT04484909	Borderline Rese... Locally Advance... Resectable Panc... Stage III Pancr...	Hafnium Oxide-c... Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma	NCT06398587	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Onvansertib Gemcitabine Nab-paclitaxel Electrocardiogr... Magnetic Resona... Positron Emissi... Biospecimen Col... Biospecimen Col... Computed Tomogr...	18 Years -	OHSU Knight Cancer Institute
Targeted Pathway Inhibition in Patients With Pancreatic Cancer	NCT04005690	Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa...	Cobimetinib Olaparib Onvansertib Azenosertib	18 Years -	OHSU Knight Cancer Institute
Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma	NCT04292743	Locally Advance... Metastatic Panc...	Eryaspase FOLFIRINOX	18 Years -	Georgetown University
Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma	NCT04292743	Locally Advance... Metastatic Panc...	Eryaspase FOLFIRINOX	18 Years -	Georgetown University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: